MRE11 and neoplasm: Emerging evidence highlights MRE11 as a promising biomarker for radiosensitivity strategies: elevated tumor MRE11 levels correlate with poor survival in radiotherapy patients, while ionizing radiation-induced MRE11 truncation promotes radioresistance 24, 48.